T. Rowe Price Exchange-Traded Funds, Inc.. Holdings as of Jun 30, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| ELI LILLY & COLLY | 16.71% | $3.85M | 3,209 |
| UNITEDHEALTH GROUP INCUNH | 6.52% | $1.50M | 3,614 |
| GILEAD SCIENCES INCGILD | 4.44% | $1.02M | 8,084 |
| THERMO FISHER SCIENTIFIC INCTMO | 4.11% | $947.57K | 1,890 |
| DANAHER CORPDHR | 2.96% | $681.92K | 3,580 |
| CENCORA INCCOR | 2.75% | $633.88K | 2,240 |
| AGILENT TECHNOLOGIES INCA | 2.61% | $601.72K | 4,530 |
| ALNYLAM PHARMACEUTICALS INCALNY | 2.60% | $597.85K | 1,986 |
| INTUITIVE SURGICAL INCISRG | 2.43% | $560.73K | 1,410 |
| INSULET CORPPODD | 2.38% | $548.25K | 3,601 |
| STRYKER CORPSYK | 2.22% | $511.30K | 1,624 |
| DYNE THERAPEUTICS INCDYN | 2.03% | $467.94K | 21,069 |
| ELANCO ANIMAL HEALTH INCELAN | 1.91% | $439.63K | 17,864 |
| PFIZER INCPFE | 1.91% | $438.93K | 18,228 |
| CYTOKINETICS INCCYTK | 1.69% | $388.81K | 4,564 |
| WATERS CORPWAT | 1.68% | $387.79K | 1,034 |
| WEST PHARMACEUTICAL SERVICESWST | 1.65% | $380.54K | 1,060 |
| ASCENDIS PHARMA A/S | 1.60% | $368.61K | 1,382 |
| BIOGEN INCBIIB | 1.55% | $357.36K | 1,654 |
| MCKESSON CORPMCK | 1.46% | $335.49K | 444 |
| DEXCOM INCDXCM | 1.46% | $335.13K | 4,976 |
| IMMUNOME INCIMNM | 1.38% | $318.04K | 15,009 |
| BIONTECH SE-ADRBNTX | 1.29% | $296.64K | 3,188 |
| HUMANA INCHUM | 1.24% | $286.40K | 721 |
| DENALI THERAPEUTICS INCDNLI | 1.22% | $281.94K | 10,962 |
| CVS HEALTH CORPCVS | 1.22% | $281.07K | 2,717 |
| IDEXX LABORATORIES INCIDXX | 1.18% | $271.12K | 515 |
| VAXCYTE INCPCVX | 1.18% | $270.60K | 4,655 |
| METTLER-TOLEDO INTERNATIONALMTD | 0.97% | $222.29K | 174 |
| HCA HEALTHCARE INCHCA | 0.95% | $219.12K | 562 |
| IMMATICS NV | 0.87% | $199.78K | 19,722 |
| REPLIGEN CORPRGEN | 0.85% | $195.11K | 1,430 |
| ELEVANCE HEALTH INCELV | 0.77% | $176.35K | 456 |
| SHATTUCK LABS INCSTTK | 0.76% | $175.92K | 25,348 |
| APOGEE THERAPEUTICS INC | 0.75% | $173.74K | 1,309 |
| STATE STREET INS US GO MM FD-ISCash or money market | 0.73% | $169.17K | 169,172 |
| BECTON DICKINSON AND COBDX | 0.72% | $166.16K | 1,098 |
| MOONLAKE IMMUNOTHERAPEUTICSMLTX | 0.66% | $152.31K | 7,823 |
| COOPER COS INC/THECOO | 0.65% | $149.73K | 2,088 |
| CABALETTA BIO INCCABA | 0.62% | $142.00K | 45,659 |
| CG ONCOLOGY INCCGON | 0.62% | $141.82K | 1,996 |
| TENET HEALTHCARE CORPTHC | 0.56% | $129.65K | 693 |
| BICARA THERAPEUTICS INCBCAX | 0.53% | $121.82K | 4,103 |
| ALIGNMENT HEALTHCARE INCALHC | 0.50% | $115.24K | 4,840 |
| SAREPTA THERAPEUTICS INCSRPT | 0.47% | $109.04K | 6,068 |
| KYMERA THERAPEUTICS INCKYMR | 0.47% | $108.82K | 949 |
| REVVITY INCRVTY | 0.45% | $103.03K | 926 |
| ADAPTIVE BIOTECHNOLOGIESADPT | 0.42% | $96.07K | 4,479 |
| MOLINA HEALTHCARE INCMOH | 0.41% | $95.14K | 416 |
| BEONE MEDICINES LTD-ADRONC | 0.40% | $91.76K | 322 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.